Dalin Tang

Title: Dalin Tang: Innovator in Crystalline Forms

Introduction

Dalin Tang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical innovations, particularly in the development of crystalline forms of various compounds. With a total of 3 patents to his name, Tang's work focuses on modulating the androgen receptor, which has important implications for treatment methods.

Latest Patents

Dalin Tang's latest patents include two notable inventions. The first patent relates to crystalline forms of (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)indoline-5-carbonitrile, a modulator of the androgen receptor, and methods for its use in treatment. The second patent also pertains to crystalline forms of (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile, further emphasizing his focus on this area of research.

Career Highlights

Dalin Tang is currently associated with GlaxoSmithKline Intellectual Property (No. 2) Limited, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing the understanding and application of crystalline forms in drug development.

Collaborations

Dalin Tang collaborates with Istvan Kaldor, a fellow innovator in the field. Their partnership enhances the research and development efforts within their organization, leading to groundbreaking advancements in pharmaceutical technology.

Conclusion

Dalin Tang's contributions to the field of crystalline forms and androgen receptor modulation highlight his role as a key inventor in the pharmaceutical industry. His ongoing work promises to yield significant advancements in treatment methodologies.